For generations, Sickle Cell Disease has been a devastating illness affecting millions of people around the world, ...

The recent authorization by the FDA of the inaugural gene therapy for genetic-related hearing impairment signifies a ...

A team of researchers led by Luigi Naldini at the San Raffael Institute for Gene Therapy (SR-Tiget) has developed a new ...

Shrank is president and co-founder of cell and gene therapy (CGT) startup Aradigm, which is working with patients, payers, ...

Treatments aim to bulk up failing hearts to restore their vigour – but can the field move on from past controversy?

Children's Mercy is expanding its cell and gene therapy program with the help of artificial intelligence (AI).

Industry focus eBook - Cell and gene therapy (2nd edition) eBook Download a collection of the top interviews, articles, and news in the cell and gene therapy industry. Download the latest edition At ...

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk ...

Labroots and the Cell & Gene Therapy planning committee are thrilled to announce the 2nd Annual Cell & Gene Therapy Virtual Event Series, live on October 15, 2025. This free, interactive event brings ...

In a worldwide first, a one-and-done gene therapy has been approved to treat a form of hereditary deafness. Many of the ...

Researchers have identified how cells recognize and suppress transposons, mobile DNA elements that can destabilize genomes.

Key market opportunities in cell and gene therapy arise from investment tracking, strategic partnerships, and industry innovations. The publication offers insights into market trends and developments, ...